CAMDEN, N.J., Dec. 4, 2023 /PRNewswire/ — The following notice is being issued by the Court approved Class Administrator and has been authorized by the U.S. District Court for the District of New Jersey, in In re: Valsartan, Losartan, and Irbesartan Products Liability Litigation, Case No….